chronic kidney disease
Conditions
Interventions
Gold Standard:Urinary microalbumin: ImmunoturbidimetryUrinary a1-microglobulin: ImmunoturbidimetryUrinary ß2-microglobulin: ImmunoassayUrinary RBP: ImmunoassayUrinary NGAL: ImmunoassayUrinary Cys-C: P
Index test:Urinary chronic kidney disease biomarkers were detected using a chemiluminescence immunoassay kit, including microalbumin, a1-microglobulin, ß2-microglobulin, RBP, NGAL, Cys-C, and creatini
Sponsors
Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years; 2.Requiring detection of biological markers of chronic kidney disease in urine, including but not limited to: Patients with diabetes, patients with hypertension, individuals with family history of chronic kidney disease, individuals with abnormal routine urinalysis found during physical examination, individuals with other high-risk factors for chronic kidney disease, and follow-up monitoring of patients with chronic kidney disease; 3.Signed informed consent;
Exclusion criteria
Exclusion criteria: 1.Anuria or insufficient urine volume to provide adequate samples; 2.Unable to cooperate with urine collection; 3.Uncontrolled psychiatric disorders or non-compliance with procedures; 4.Deemed unsuitable for inclusion in this study by the investigator;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Urinary microalbumin;Urinary a1-microglobulin;Urinary ß2-microglobulin;Urinary cystatin C (Cys-C);Urinary creatinine;Urinary retinol-binding protein(RBP);Urinary neutrophil gelatinase-associated lipocalin (NGAL); | — |
Countries
China
Contacts
Public ContactHaijiao Jin
Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine
Outcome results
None listed